Abiomed Announces Preliminary Q3 Results, Slashes View Zacks

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Jan 14, 2020 at 10:12 AM.

  1. #1 cafead, Jan 14, 2020 at 10:12 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,937
    Likes Received:
    3
    via ABIOMED, Inc. ABMD recently announced preliminary results for third-quarter fiscal 2020.

    Revenues are anticipated at $221.6 million, suggesting a 10% year-over-year rise but below the Zacks Consensus Estimate of $227.1 million.

    article source
     
    Quote

Reply to Thread